Biora Therapeutics, Inc. (BIOR) Earnings Report - Discounting Cash Flows
BIOR
Biora Therapeutics, Inc.
BIOR (OTC)
Period Ending: 2025
11-12
2025
08-15
2025
05-29
2025
03-25
2024
11-14
2024
08-12
2024
05-15
2024
03-26
2023
11-13
2023
08-14
2023
05-15
2023
03-30
2022
11-14
2022
08-15
2022
05-10
2022
03-28
2021
11-10
2021
08-12
2021
05-13
2021
03-18
2020
11-09
2020
08-13
2020
06-22
2020
03-31
2019
09-29
2019
06-29
2019
03-31
2018
12-30
Actual EPS - - - - -6.08 -3.50 -6.10 -6.30 -7.50 -14.70 -15.90 -16.10 -20.00 -7.50 -30.00 -14.00 -11.50 -16.25 -14.00 -38.25 -25.25 -152.75 -35.99 -9.49 -40.74 -11.70 -17.13 -374.62
Estimated EPS - - - -3.30 -3.85 -4.50 -4.50 -6.00 -9.30 -16.00 -1.75 -8.90 -15.00 -32.50 -30.00 -4.00 -11.17 -20.17 -20.30 -20.55 -17.90 -20.75 - - - - - -
Actual Revenue - - - - 0.032 0.318 0.542 0.872 - 0.002 0.002 0.014 0.08 0.104 0.107 0.435 0.182 0.463 24.53 14.28 25.94 17.27 20.48 16.83 18.77 57.23 47.51 -4
Estimated Revenue - 0.23 0.23 0.23 0.23 - - 0.001 - 0.02 - 0.05 0.1 - 0.107 0.25 - - - - - - - - - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program